Augustine Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Hold
1,270
0.31% 42
2026
Q1
$1.17M Buy
1,270
+4
+0.3% +$4.05K 0.26% 50
2025
Q4
$1.36M Sell
1,266
-7
-0.5% -$6.69K 0.27% 47
2025
Q3
$971K Buy
1,273
+33
+3% +$24.6K 0.2% 53
2025
Q2
$967K Buy
1,240
+93
+8% +$72.3K 0.26% 53
2025
Q1
$947K Sell
1,147
-481
-30% -$400K 0.28% 51
2024
Q4
$1.26M Buy
1,628
+1,221
+300% +$1.01M 0.33% 47
2024
Q3
$361K Buy
407
+3
+0.7% +$2.7K 0.13% 69
2024
Q2
$366K Sell
404
-9
-2% -$7.2K 0.14% 63
2024
Q1
$321K Sell
413
-6
-1% -$4.27K 0.13% 66
2023
Q4
$244K Sell
419
-40
-9% -$23.3K 0.11% 85
2023
Q3
$247K Buy
+459
New +$237K 0.11% 89
2022
Q3
Sell
-1,423
Closed -$461K 92
2022
Q2
$461K Buy
1,423
+12
+0.9% +$3.6K 0.28% 46
2022
Q1
$404K Buy
1,411
+90
+7% +$23.2K 0.2% 58
2021
Q4
$365K Hold
1,321
0.18% 61
2021
Q3
$305K Buy
1,321
+69
+6% +$17K 0.16% 74
2021
Q2
$287K Buy
1,252
+7
+0.6% +$1.41K 0.15% 74
2021
Q1
$233K Buy
1,245
+9
+0.7% +$1.76K 0.12% 74
2020
Q4
$209K Buy
+1,236
New +$185K 0.11% 76

Other funds holding LLY

Augustine Asset Management's LLY Position: Q2 2026 in Review

Augustine Asset Management held its Eli Lilly (LLY) position steady in Q2 2026 at 1,270 shares worth $1.52M. The position accounts for 0.31% of the portfolio, ranked #42.

Augustine Asset Management first reported a position in LLY in Q4 2020 and has held it in 19 quarters since. 764 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Augustine Asset Management held 1,270 shares of Eli Lilly worth $1.52M as of Q2 2026.
  • Augustine Asset Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.31% of Augustine Asset Management's portfolio in Q2 2026, its #42 holding.
  • Augustine Asset Management first reported a position in Eli Lilly in Q4 2020 and has held it in 19 quarters since.
  • 764 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Augustine Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.